Cordis expands vena cava filter use in Europe:
This article was originally published in Clinica
Executive Summary
Cordis Endovascular has gained the go-ahead in Europe to expand the market for its 6F Trapease permanent vena cava filter for preventing pulmonary embolism. The device can now be used in larger vena cava diameters - ranging from between 18-30mm as well as in those less than 18mm in diameter, says the Warren, New Jersey-based unit of Cordis, a Johnson & Johnson company.